Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Synergic effects between ocellatin-F1 and bufotenine on the inhibition of BHK-21 cellular infection by the rabies virus

Texto completo
Autor(es):
Cunha Neto, Rene dos Santos [1, 2] ; Vigerelli, Hugo [1] ; Jared, Carlos [3] ; Antoniazzi, Marta Maria [3] ; Chaves, Luciana Botelho [2] ; Rodrigues da Silva, Andrea de Cassia [2] ; de Melo, Robson Lopes [4] ; Sciani, Juliana Mozer [1] ; Pimenta, Daniel C. [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Butantan Inst, Biochem & Biophys Lab, BR-05503900 Sao Paulo, SP - Brazil
[2] Inst Pasteur, Lab Rabies Diagnost, Serol, BR-01311000 Sao Paulo - Brazil
[3] Butantan Inst, Cell Biol Lab, BR-05503900 Sao Paulo, SP - Brazil
[4] Butantan Inst, Special Lab Toxinol, BR-05503900 Sao Paulo, SP - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Journal of Venomous Animals and Toxins including Tropical Diseases; v. 21, DEC 2 2015.
Citações Web of Science: 7
Resumo

Background: Rabies is an incurable neglected zoonosis with worldwide distribution characterized as a lethal progressive acute encephalitis caused by a lyssavirus. Animal venoms and secretions have long been studied as new bioactive molecular sources, presenting a wide spectrum of biological effects, including new antiviral agents. Bufotenine, for instance, is an alkaloid isolated from the skin secretion of the anuran Rhinella jimi that inhibits cellular penetration by the rabies virus. Antimicrobial peptides, such as ocellatin-P1 and ocellatin-F1, are present in the skin secretion of anurans from the genus Leptodactylus and provide chemical defense against predators and microorganisms. Methods: Skin secretion from captive Leptodactylus labyrinthicus was collected by mechanical stimulation, analyzed by liquid chromatography and mass spectrometry, and assayed for antiviral and cytotoxic activities. Synthetic peptides were obtained using solid phase peptide synthesis, purified by liquid chromatography and structurally characterized by mass spectrometry, and assayed in the same models. Cytotoxicity assays based on changes in cellular morphology were performed using baby hamster kidney (BHK-21) cells. Fixed Rabies virus (Pasteur Virus - PV) strain was used for virological assays based on rapid fluorescent focus inhibition test. Results: Herein, we describe a synergic effect between ocellatin-F1 and bufotenine. This synergism was observed when screening the L. labyrinthicus skin secretion for antiviral activities. The active fraction major component was the antimicrobial peptide ocellatin-F1. Nevertheless, when the pure synthetic peptide was assayed, little antiviral activity was detectable. In-depth analyses of the active fraction revealed the presence of residual alkaloids together with ocellatin-F1. By adding sub-effective doses (e.g. < IC50) of pure bufotenine to synthetic ocellatin-F1, the antiviral effect was regained. Moreover, a tetrapetide derived from ocellatin-F1, based on alignment with the virus's glycoprotein region inferred as a possible cell ligand, was able to maintain the synergic antiviral activity displayed by the full peptide. Conclusions: This novel antiviral synergic effect between a peptide and an alkaloid may present an innovative lead for the study of new antiviral drugs. (AU)

Processo FAPESP: 12/11280-1 - Análise do possível efeito de componentes da secreção cutânea de Leptodactylus labyrinthicus como interferentes na penetração do vírus da raiva em células de mamíferos
Beneficiário:Rene dos Santos Cunha Neto
Linha de fomento: Bolsas no Brasil - Mestrado